Bendamustine Plus Rituximab as First-Line Lymphoma Treatment
Bendamustine Plus Rituximab as First-Line Lymphoma Treatment
P Wendling
20091116
2009 Dec 16
Elsevier Global Medical News
Find more items about these cancer types:
Bendamustine Plus Rituximab as First-Line Lymphoma Treatment
(00:03:27) Elsevier Global Medical News, 2009 Dec 16, P Wendling
Bendamustine plus rituximab has the potential to replace standard CHOP chemotherapy plus rituximab in the first-line treatment of advanced lymphomas. Dr. Mathias J. Rummel discusses data presented at the 2009 annual meeting of the American Society of Hematology.
/Images/Dr_Mathias_Rummel_tcm8-231421.jpg
See related videos to:
ASH 2009
Copyright © 2010 International Medical News Group
Subscribe Now »
Subscribe Now »
Most Viewed Video
Expert Gives Overview of Gamechangers at 2011 ASCO Annual Meeting
Elsevier Global Medical News, 2011 Jun 4
